GlassScriptPhysician profile
Vincent Sghiatti
NPI 1750469318
$2,795.38
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $401 · 2021: $1,064 · 2022: $531 · 2023: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $372.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $795.70 | 2021-2023 | Vraylar |
| Glaxosmithkline, LLC. | $386.56 | 2020-2023 | |
| Novo Nordisk INC | $345.77 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $342.60 | 2020-2022 | |
| Ferring Pharmaceuticals INC. | $158.34 | 2019-2023 | Rebyota |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.50 | 2021 | |
| Allergan, INC. | $89.31 | 2020 | |
| Lilly USA, LLC | $88.70 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $80.85 | 2022-2023 | Farxiga |
| Pfizer INC. | $71.92 | 2020-2023 | |
| Horizon Therapeutics Plc | $71.53 | 2019-2020 | |
| Roche Diagnostics Corporation | $40.38 | 2019 | |
| Eisai INC. | $37.06 | 2020-2021 | |
| Ermi LLC | $29.78 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $24.66 | 2023 | Qelbree |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $23.05 | 2019 | |
| Exeltis, USA INC. | $22.51 | 2019 | |
| Alnylam Pharmaceuticals INC. | $22.18 | 2021 | |
| Linus Health, INC. | $21.51 | 2022 | |
| Aytu Biopharma, INC. | $19.18 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.69 | 2022 | |
| Optos, INC. | $10.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Sghiatti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.